Compass Therapeutics, Inc. (CMPX) Form 10-K Annual Reports
Compass Therapeutics, Inc. (CMPX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CMPX
CIK: 1738021
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CohnReznick LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMichael Monahan
Audit LocationMelville, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001171843-26-006349 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 Filing | 0001171843-26-006235 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | FORM 8-K | 0001171843-26-006162 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001213900-26-089989 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000440 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | FORM 10-Q | 0001171843-26-005295 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001171843-26-005292 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | FORM 8-K | 0001171843-26-004428 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-22 | FORM 8-K | 0001171843-26-004224 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | FORM 8-K | 0001171843-26-004068 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000921895-26-001388 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | FORM 10-Q | 0001171843-26-003006 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | FORM 8-K | 0001171843-26-003005 | View SEC Doc Filr Page |
| 4/A | 2026-04-30 | 2026-04-29 | 4/A Filing | 0001171843-26-002894 | View SEC Doc Filr Page |
| 4/A | 2026-04-30 | 2026-04-29 | 4/A Filing | 0001171843-26-002893 | View SEC Doc Filr Page |
| 4 | 2026-04-29 | 2026-04-29 | 4 Filing | 0001171843-26-002840 | View SEC Doc Filr Page |
| 4 | 2026-04-29 | 2026-04-29 | 4 Filing | 0001171843-26-002834 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001140361-26-017651 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001140361-26-017650 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-10 | DEF 14A | 0001140361-26-017649 | View SEC Doc Filr Page |
| 8-K | 2026-04-27 | 2026-04-27 | FORM 8-K | 0001171843-26-002720 | View SEC Doc Filr Page |
| S-8 | 2026-03-12 | — | S-8 | 0001193125-26-103115 | View SEC Doc Filr Page |
| 10-K | 2026-03-05 | 2025-12-31 | FORM 10-K | 0001171843-26-001337 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-03-05 | FORM 8-K | 0001171843-26-001336 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001193125-26-051513 | View SEC Doc Filr Page |